Casdin Capital, LLC 13D/13G Filings for BioLife Solutions, Inc. (BLFS)

Casdin Capital, LLC 13D and 13G filings for BioLife Solutions, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-06-12
9:10 pm
Sale		 2025-06-10 13D BioLife Solutions, Inc.
BLFS		 Casdin Capital, LLC 7,707,165
16.200%		 -1,027,994decrease
(-11.77%)		 Filing
2025-04-09
5:13 pm
Purchase		 2025-04-07 13D BioLife Solutions, Inc.
BLFS		 Casdin Capital, LLC 8,735,159
18.500%		 27,994increase
(+0.32%)		 Filing
2023-10-24
4:29 pm
Purchase		 2023-10-19 13D BioLife Solutions, Inc.
BLFS		 Casdin Capital, LLC 8,707,165
19.500%		 1,267,058increase
(+17.03%)		 Filing
2021-02-11
10:25 am
Purchase		 2020-12-31 13G BioLife Solutions, Inc.
BLFS		 Casdin Capital, LLC 3,346,035
6.930%		 247,913increase
(+8.00%)		 Filing
2021-02-11
10:19 am
Purchase		 2020-12-31 13G BioLife Solutions, Inc.
BLFS		 Casdin Capital, LLC 12,298,038
6.370%		 3,264,095increase
(+36.13%)		 Filing
2020-11-27
5:21 pm
Purchase		 2020-11-24 13D BioLife Solutions, Inc.
BLFS		 Casdin Capital, LLC 7,440,107
22.700%		 3,066,774increase
(+70.12%)		 Filing